You are here:
Home
NICE Guidance
Conditions and diseases
Blood and immune system conditions
Blood and bone marrow cancers
Magrolimab with azacitidine for untreated myelodysplastic syndromes [ID3978]
Discontinued
Reference number:
GID-TA10861
Project information
Project documents
Documents
Documents created during the development process.
Notes
Note
Note
Back to top